Product Images Rythmol SR

This appears to be a report or analysis of a clinical trial involving the drugs Rythmol SR and Propafenone SR at different dosages compared to a placebo. The graph shows the proportion of patients who did not have an event (not defined) over time, with patients at risk listed at different time points. There is a significant difference between the groups, with Rythmol SR showing the best results. On day 291, one patient on 325 mg Propafenone SR had an event.*

This is a description of a medication package with the code A146369. It contains 60 extended-release capsules of Rythmol SR, a prescription drug used to treat heart rhythm disorders. The package has a GTIN number, an NDC code, and a trademark owned by GSK. The usual dosage and storage instructions are provided, including a caution about the broken or missing capsule opening. The manufacturer is Marutackred, and the drug is made in Germany.*

This is a description for a medication labeled as NDC 0173-0824-18, which is an extended-release capsule of a drug called propafenone. The usual dosage and storage recommendations are noted, and the potential issue of a broken or missing seal on the capsule is mentioned. The medicine should be kept in a container with USP guidelines and at a temperature range of 15°C to 30°C (59°F to 86°F). The trademark is owned by or licensed to GSK, and the capsules were manufactured in Germany. The text includes a revision date of 6117.*

This is a description of a medication called RythmolSR. The medication is contained in extended-release capsules that are available in 60 counts and are trademarked by GSK. The usual dosage information is given in accompanying literature. The medication is manufactured for research purposes and the details of the manufacturer are also given. The NDC number of the medication is 0173-0826-18.*